Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Diane, Piper"'
Autor:
Rebecca Arend, Jhalak Dholakia, Cesar Castro, Ursula Matulonis, Erika Hamilton, Camille Gunderson Jackson, Kristopher LyBarger, Howard M. Goodman, Linda R. Duska, Haider Mahdi, Adam C. ElNaggar, Michael H. Kagey, Amy Liu, Diane Piper, Lisa M. Barroilhet, William Bradley, Jasgit Sachdev, Cynthia A. Sirard, David M. O'Malley, Michael Birrer
Publikováno v:
Gynecologic Oncology. 172:82-91
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3119dea5b8a715375b4afd1711f2bd14
https://doi.org/10.1016/j.ygyno.2023.03.013
https://doi.org/10.1016/j.ygyno.2023.03.013
Autor:
Jason J. Luke, Jedd D. Wolchok, Taha Merghoub, Cynthia A. Sirard, Diane Piper, Lianna Sifferlen, Phillip Wong, Aliya Holland, Jingjing Qi, Walter Newman, Olivier Rixe, David Bajor, Todd Bauer, Takami Sato, Girish S. Naik, Hong Wang, Roberta Zappasodi, Diwakar Davar
Supplementary Table from Phase IB Study of GITR Agonist Antibody TRX518 Singly and in Combination with Gemcitabine, Pembrolizumab, or Nivolumab in Patients with Advanced Solid Tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06e8274a662db94b0372cb7e7542e809
https://doi.org/10.1158/1078-0432.22486856
https://doi.org/10.1158/1078-0432.22486856
Autor:
Jason J. Luke, Jedd D. Wolchok, Taha Merghoub, Cynthia A. Sirard, Diane Piper, Lianna Sifferlen, Phillip Wong, Aliya Holland, Jingjing Qi, Walter Newman, Olivier Rixe, David Bajor, Todd Bauer, Takami Sato, Girish S. Naik, Hong Wang, Roberta Zappasodi, Diwakar Davar
Purpose:TRX518 is a mAb engaging the glucocorticoid-induced TNF receptor−related protein (GITR). This open-label, phase I study (TRX518-003) evaluated the safety and efficacy of repeated dose TRX518 monotherapy and in combination with gemcitabine,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d505d5d9e72ee2c945357f5aef741ec3
https://doi.org/10.1158/1078-0432.c.6532406.v1
https://doi.org/10.1158/1078-0432.c.6532406.v1
Autor:
Jason J. Luke, Jedd D. Wolchok, Taha Merghoub, Cynthia A. Sirard, Diane Piper, Lianna Sifferlen, Phillip Wong, Aliya Holland, Jingjing Qi, Walter Newman, Olivier Rixe, David Bajor, Todd Bauer, Takami Sato, Girish S. Naik, Hong Wang, Roberta Zappasodi, Diwakar Davar
Supplementary Data from Phase IB Study of GITR Agonist Antibody TRX518 Singly and in Combination with Gemcitabine, Pembrolizumab, or Nivolumab in Patients with Advanced Solid Tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b804d37d72c5b64ee02158bbc8605da
https://doi.org/10.1158/1078-0432.22486880
https://doi.org/10.1158/1078-0432.22486880
Autor:
Jason J. Luke, Jedd D. Wolchok, Taha Merghoub, Cynthia A. Sirard, Diane Piper, Lianna Sifferlen, Phillip Wong, Aliya Holland, Jingjing Qi, Walter Newman, Olivier Rixe, David Bajor, Todd Bauer, Takami Sato, Girish S. Naik, Hong Wang, Roberta Zappasodi, Diwakar Davar
Supplementary Figure from Phase IB Study of GITR Agonist Antibody TRX518 Singly and in Combination with Gemcitabine, Pembrolizumab, or Nivolumab in Patients with Advanced Solid Tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3addefab290e824d920fb0999caa57c8
https://doi.org/10.1158/1078-0432.22486877
https://doi.org/10.1158/1078-0432.22486877
Autor:
Diwakar Davar, Roberta Zappasodi, Hong Wang, Girish S. Naik, Takami Sato, Todd Bauer, David Bajor, Olivier Rixe, Walter Newman, Jingjing Qi, Aliya Holland, Phillip Wong, Lianna Sifferlen, Diane Piper, Cynthia A. Sirard, Taha Merghoub, Jedd D. Wolchok, Jason J. Luke
Publikováno v:
Clin Cancer Res
Purpose: TRX518 is a mAb engaging the glucocorticoid-induced TNF receptor−related protein (GITR). This open-label, phase I study (TRX518-003) evaluated the safety and efficacy of repeated dose TRX518 monotherapy and in combination with gemcitabine,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60473b0d4d51a50755b6880e00e30770
https://europepmc.org/articles/PMC9475244/
https://europepmc.org/articles/PMC9475244/
Autor:
Joseph, Muenzer, James E, Wraith, Michael, Beck, Roberto, Giugliani, Paul, Harmatz, Christine M, Eng, Ashok, Vellodi, Rick, Martin, Uma, Ramaswami, Muge, Gucsavas-Calikoglu, Suresh, Vijayaraghavan, Susanne, Wendt, Suzanne, Wendt, Ana Cristina, Puga, Antonio, Puga, Brian, Ulbrich, Marwan, Shinawi, Maureen, Cleary, Diane, Piper, Anne Marie, Conway, Ann Marie, Conway, Alan, Kimura
Publikováno v:
Genetics in Medicine. 8:465-473
Purpose: To evaluate the safety and efficacy of recombinant human iduronate-2-sulfatase (idursulfase) in the treatment of mucopolysaccharidosis II. Methods: Ninety-six mucopolysaccharidosis II patients between 5 and 31 years of age were enrolled in a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc9ed62ed0dbcc159b373e89c37ba401
https://doi.org/10.1097/01.gim.0000232477.37660.fb
https://doi.org/10.1097/01.gim.0000232477.37660.fb
Autor:
David M. Livermore, H. Y. Chen, M. Allen, Diane Piper, G. Bonfiglio, Tracey Edwardson, Donna McVey
Publikováno v:
Journal of Antimicrobial Chemotherapy. 32:247-266
Twenty-nine British and Irish hospitals each collected up to 300 bacterial isolates from in-patients. The organisms were identified by an appropriate API system or, for staphylococci, by their Gram and coagulase reactions. Disc susceptibility tests w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::556b40b1ffa06a404b05f508c83f7648
https://doi.org/10.1093/jac/32.2.247
https://doi.org/10.1093/jac/32.2.247
Autor:
Diane Piper, Ana Cristina Puga, Anne Marie Conway, Marwan Shinawi, Brian Ulbrich, Maureen Cleary, Joseph Muenzer, Susanne Wendt, James E. Wraith, Ashok Vellodi, Michael Beck, Suresh Vijayaraghavan, Paul Harmatz, Roberto Giugliani, Alan Kimura, Uma Ramaswami, Muge Gucsavas-Calikoglu, Richard M. Martin, Christine M. Eng
Publikováno v:
Genetics in Medicine. 8:599
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::98dc23c4867d1d641b49b7b5b420c0a0
https://doi.org/10.1097/00125817-200609000-00009
https://doi.org/10.1097/00125817-200609000-00009